Healthcare Success

  The pharmacy automation systems market was mainly dominated by McKesson Corporation and CareFusion Corporation, collectively holding around half of the global market share in 2013. Besides McKesson and CareFusion, none of the other major players in the market have a share of more than 15%. However, there are a limited number of local players in the market that cater to their respective domestic and regional markets. In the past few years, growing competition from companies like Cerner, Omnicell, InterMetro, Baxter, and Swisslog has challenged the market dominance of the top two players. With a strong distribution network as well as a strong retail pharmacy solutions portfolio, Cerner Corporation is also emerging as one of the leading players in the pharmacy automation systems market. The leading position of McKesson can mainly be attributed to its well-established position in the pharmaceutical distribution business in the U.S. and Canada as well as its strong portfolio of pharma...

  The HCS service market showcases a lucrative growth potential. This market includes services related to various phases of drug discovery such as target identification and target validation, primary screening, secondary screening and toxicity studies, and compound profiling among others. Among these services, primary screening represents the new revenue pocket for the HCS market. Across the globe, the adoption of high content screening for primary screening is increasing due to factors such as increased throughput, enhanced accuracy, and ease of use. A number of automated HCS instruments are available in the market. Moreover, market players are engaged in developing new automated HCS instruments with higher throughput, which will help the market grow further. Taking into consideration the growing demand for HCS products, various venture capitalists are now investing in this market. For instance, in November 2011, the Entrepreneurs Fund (U.K.) and Sham (France) invested $10 million...

  The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent in the coming years. To know about the assumptions considered for the study  download the pdf brochure The global anatomic pathology market for instruments and consumables is consolidated. The top five companies in this market are F. Hoffmann-La Roche AG...

  The 3D Printing Medical Devices market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period. Growth in this market is primarily driven by technological advancements towards the development of biocompatible materials; increased funding, research grants, and public-private investments; and growing government initiatives to improve healthcare infrastructure of hospitals; However, the lack of skilled technicians is expected to limit market growth in the coming years. Complex regulatory frameworks that delay the approval of new 3D Printing Medical Devices are also expected to challenge market growth to a certain extent. The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2017–2020 to expand their global presence and increase their market shares in the 3D Printing Medical Devices market. The key growth strategies adopted by the top players in the market include...

  The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. Growth in the particle therapy market can be attributed to factors such as the various advantages offered by particle therapy over photon therapy, increasing adoption of particle therapy in clinical trials, growing global prevalence of cancer, and the increasing number of particle therapy centers worldwide. On the other hand, issues related to the affordability and accessibility of treatments and the unfavorable reimbursement policies for particle therapy are the major factors that are expected to restrain the growth of this market in the coming years. The major players operating in the particle therapy market include Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), and Hitachi, Ltd. (Japan). Other players operating in this market include Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Lt...

  The global transfer membrane market is projected to reach 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5%. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to propel the growth of transfer membrane market. As of 2017, some of the prominent players in the transfer membrane market were Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India),. Analysis of the developments in transfer membrane market during period of 2015 and 2018 shows that acquisitions was the most widely adopted growth strateg...

  The global biomaterials market size is projected to reach USD  47.5 billion by 2025 from USD  35.5  billion in 2020, at a CAGR of 6.0% during the forecast period. Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine . In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years. The global biomaterials market is highly consolidated. Key players in the biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Neth...

  The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth. Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the western blotting market. To know about the assumptions considered for the study  download the pdf brochure BIO-RAD LABORATORIES, INC. (US) Bio-Rad Laboratories is a leading player in the western blotting market in 2020. The company is a leading manufacturer and supplier of products and systems to separate, detect, analyze, and purify complex biological and chemical materials. The company’s leading position in the market can ...

  The inspection machines market is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period. The growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices (GMP), the increasing adoption of automated inspection systems in the pharmaceutical and biotechnology industries, growth in the number of product recalls, an increasing number of inspection checkpoints throughout the production line, and technological advancements in inspection systems support the growth of the market. However, the growing demand for used and refurbished inspection systems is expected to restrain this markets growth to a certain extent. The global inspection machines market is consolidated at the top, with a large number of leading market players based in developed countries. The prominent players in this market are Robert Bosch Gmb...

  The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. The growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe, increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers support the growth of the market. However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this markets growth to a certain extent. The women’s health diagnostics market is highly competitive. The prominent companies in this market are Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Siemens AG (Germany), PerkinElmer, Inc. (US), F. Hoffmann-La Roche Ltd. (Swi...

  The global cold plasma market size is projected to reach USD 3.3 billion by 2026 from USD 1.6 billion in 2021, at a CAGR of 15.0% during the forecast period. Innovations in textile production and growing food safety concerns are the major factors driving the growth of this market. Also, in the current regulatory climate–where the focus on sustainable techniques has risen—it is expected that the benefits of cold plasma will ensure its greater adoption in the coming years. Players in the global cold plasma industry such as Apyx Medical Corporation (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i (UK), Relyon Plasma GmbH, (Germany), Henniker Plasma (UK), Enercon Industries (US), AcXys Plasma Technologies (France), Plasmatreat (Germany), Tantec A/S (Denmark), Europlasma (Belgium), Thierry Corporation (Germany), Surfx Technologies, LLC (US), SOFTAL Corona & Plasma (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas G...

  The global oncology nutrition market is projected to reach USD 2.21 Billion by 2023 from USD 1.46 Billion in 2018, at a CAGR of 8.7%. This market is highly consolidated in nature, with the top four players accounting for around 87.4% of the market in 2017. The leading market players are based across developed countries such as the US, Germany, France, and Switzerland. Various small and medium-sized players, operating in both developed and emerging markets, are making this a highly competitive market. In 2017, the market was dominated by Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), and Fresenius Kabi (Germany). Abbott Laboratories dominated the global oncology nutrition market in 2017. The company offers a strong product portfolio, providing a broad line of pediatric and adult oral and tube feeding nutritional products to a wide end-user base. It has a strong distribution network for its nutritional products, with facilities in about 150 countries across N...

  The global arthroscopy instruments market is estimated to be valued at USD 4.17 Billion in 2017 and is projected to reach USD 5.61 Billion by 2022, at a CAGR of 6.1% from 2017 to 2022. The factors driving the growth of this market are the growing aging population, sports and trauma injuries, advanced products and established reimbursement policies in developed nations. In addition, the increasing preference for minimally invasive procedures, favorable initiatives by governments and healthcare providers, and technological advancements are expected to support the growth of the arthroscopy instruments market during the forecast period. Analysis of the market developments between 2015 and 2017 revealed that several growth strategies such as product launches and product enhancement, strategic acquisitions, agreements, contracts, and market expansions were adopted by the market players to strengthen their product portfolios and maintain their positions in the arthroscopy instruments ma...

  The global bioinformatics market is projected to reach USD 21.8 billion by 2026 from USD 10.7 billion in 2021, at a CAGR of 15.2% during the forecast period. Bioinformatics is the application of computer technology for the management and analysis of biological data. It includes storage, analysis, and dissemination of biological data. Bioinformatics uses computer programs for a variety of applications, including determining gene & protein functions, establishing evolutionary relationships, and predicting the three-dimensional shapes of proteins. However, high costs of bioinformatics software and services and a dearth of skilled professionals are likely to challenge market growth in the coming years. Some of the prominent players operating in the bioinformatics market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics La...

  The pedicle screw systems market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018, at a CAGR of 6.1%. The major factors driving the growth of this market are the increasing incidence of spinal cord injuries, technological advancement, rising geriatric population, and the growing preference for minimally invasive surgeries. Prominent players in the market include DePuy Synthes (US), Zimmer Biomet (US) and Globus Medical (US). The key strategies followed by most companies in the pedicle screw systems market are product launches, expansions, and acquisitions. The strategy of product launches and approvals accounted for the largest share of the overall growth strategies mapped from 2015 to 2018. To know about the assumptions considered for the study  download the pdf brochure DePuy Synthes  held the leading position in the global pedicle screw systems market in 2017. The company has a strong product portfolio of pedicle system products. In ord...

  The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, inadequate reimbursements of the esoteric test may restrict market growth to a certain extent. The esoteric testing market is segmented based on type, technology, end user and region. The global esoteric testing market is consolidated. The prominent players operating in this market include Labcorp (US), Quest Diagnostics (US) and OPKO Health Inc. (US). To know about the assumptions considered for the study  download the pdf brochure Labcorp (US)  is ...

  The medical power supply market is projected to reach USD 1.8 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 6.9% during the forecast period. Growth in this market is primarily driven by technological advancements towards the development of programmable medical power supply ; increased funding, research grants, and public-private investments; growing government initiatives to improve healthcare nfrastructure of hospitals; and the emergence of modular AC-DC power supply. However, the technical limitation for conventional medical power supplies is expected to limit market growth in the coming years. Complex regulatory frameworks that delay the approval of new medical power supply are also expected to challenge market growth to a certain extent. The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2017–2020 to expand their global presence and increase their market shares in the medical power supply  market. Th...